Asuragen Raises $18.5M in Series B Financing

Dec 11, 2007

NEW YORK (GenomeWeb News) – Asuragen said yesterday that it has raised $18.5 million in Series B financing.

The funding adds to $49 million that the company raised in a Series A round last year.

Investors in the Series B round include PTV Sciences, a new investor, as well as previous investors Telegraph Hill Partners and Growth Capital Partners.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

This Week in Science

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

New Framework Suggested

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

Penguins With Roving Eyes

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Funding Lost

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Main menu